These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3290945)

  • 1. Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.
    Crook T
    Psychopharmacol Bull; 1988; 24(1):31-8. PubMed ID: 3290945
    [No Abstract]   [Full Text] [Related]  

  • 2. Memory problems in dementia: adaptation and coping strategies and psychosocial treatments.
    Dröes RM; van der Roest HG; van Mierlo L; Meiland FJ
    Expert Rev Neurother; 2011 Dec; 11(12):1769-81; quiz 1782. PubMed ID: 22091600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.
    Reger MA; Henderson ST; Hale C; Cholerton B; Baker LD; Watson GS; Hyde K; Chapman D; Craft S
    Neurobiol Aging; 2004 Mar; 25(3):311-4. PubMed ID: 15123336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutics of Alzheimer's disease for clinical and pre-clinical issues.
    Santucci AC; Haroutunian V; Tsuboyama GK; Kanof PD; Davis KL
    Prog Clin Biol Res; 1989; 317():1111-20. PubMed ID: 2690088
    [No Abstract]   [Full Text] [Related]  

  • 6. Rofecoxib in mild cognitive impairment.
    Ownby RL
    Curr Psychiatry Rep; 2006 Feb; 8(1):9-10. PubMed ID: 16513035
    [No Abstract]   [Full Text] [Related]  

  • 7. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment.
    Cherrier MM; Matsumoto AM; Amory JK; Asthana S; Bremner W; Peskind ER; Raskind MA; Craft S
    Neurology; 2005 Jun; 64(12):2063-8. PubMed ID: 15985573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [News on the Alzheimer's disease].
    Féger J
    Ann Pharm Fr; 2009 Mar; 67(2):67-8. PubMed ID: 19298888
    [No Abstract]   [Full Text] [Related]  

  • 9. Galantamine for Alzheimer's disease and mild cognitive impairment.
    Cusi C; Cantisani TA; Celani MG; Incorvaia B; Righetti E; Candelise L;
    Neuroepidemiology; 2007; 28(2):116-7. PubMed ID: 17409773
    [No Abstract]   [Full Text] [Related]  

  • 10. [Awareness of memory deficits in patients with probable Alzheimer's disease].
    Retz-Junginger P; Supprian T; Retz W; Rösler M; Traue HC
    Fortschr Neurol Psychiatr; 2005 Jun; 73(6):327-32. PubMed ID: 15942862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrine for Alzheimer's disease.
    Med Lett Drugs Ther; 1993 Sep; 35(905):87-8. PubMed ID: 8361451
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of prospective memory deficits in mild cognitive impairment of suspected Alzheimer's disease etiology using a novel event-based prospective memory task.
    Blanco-Campal A; Coen RF; Lawlor BA; Walsh JB; Burke TE
    J Int Neuropsychol Soc; 2009 Jan; 15(1):154-9. PubMed ID: 19128540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-associated memory impairment and early Alzheimer's disease. Only time will tell the difference.
    Förstl H; Hentschel F; Sattel H; Geiger-Kabisch C; Besthorn C; Czech C; Mönning U; Beyreuther K
    Arzneimittelforschung; 1995 Mar; 45(3A):394-7. PubMed ID: 7763332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting.
    Frankfort SV; Appels BA; De Boer A; Tulner LR; Van Campen JP; Koks CH; Beijnen JH
    Int J Clin Pract; 2006 Jun; 60(6):646-54. PubMed ID: 16805746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model.
    Pillay NS; Kellaway LA; Kotwal GJ
    Behav Brain Res; 2008 Oct; 192(2):173-7. PubMed ID: 18490064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axel Unterbeck on memory, cognition and the development of CNS drugs. Interview by Steve Carney.
    Unterbeck A
    Drug Discov Today; 2005 Feb; 10(3):165-8. PubMed ID: 15708528
    [No Abstract]   [Full Text] [Related]  

  • 20. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
    Kidd PM
    Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.